- Home
- OCS vs CCD Comparison
OCS vs CCD Comparison
Compare OCS & CCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OCS | CCD |
|---|---|---|
| Founded | 2003 | 2014 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 732.4M | 662.0M |
| IPO Year | 2022 | 2014 |
Fundamental Metrics
Financial Performance| Metric | OCS | CCD |
|---|---|---|
| Price | $10.07 | $22.94 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $42.00 | N/A |
| AVG Volume (30 Days) | ★ 142.9K | 49.1K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.61% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $466.06 | N/A |
| Revenue Next Year | $479.73 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.50 | $19.99 |
| 52 Week High | $34.48 | $26.99 |
Technical Indicators
Market Signals| Indicator | OCS | CCD |
|---|---|---|
| Relative Strength Index (RSI) | 24.29 | 28.10 |
| Support Level | N/A | $23.01 |
| Resistance Level | $13.49 | $26.02 |
| Average True Range (ATR) | 0.53 | 0.41 |
| MACD | -0.21 | -0.11 |
| Stochastic Oscillator | 3.42 | 2.01 |
Price Performance
Historical ComparisonAbout OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.
About CCD Calamos Dynamic Convertible & Income Fund
Calamos Dynamic Convertible and Income Fund operates as a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation. It predominantly invests in a portfolio of convertible securities, investment grade and below investment grade bonds, loans, equity-linked notes, and floating rate securities.